BMM
GWPH

Buffington Mohr McNeal’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Buffington Mohr McNeal’s Portfolio GWPH Stock Details GWPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-30
Closed -$5K – 354
2019
Q1 		$5K Buy
+30
New +$4.46K ﹤0.01% 312

Other funds holding GWPH

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
EMG
ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return

Buffington Mohr McNeal's GWPH Position: Q2 2019 in Review

Buffington Mohr McNeal sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2019, closing a stake of 30 shares — an estimated $5K sold.

Buffington Mohr McNeal first reported a position in GWPH in Q1 2019 and held it in 1 quarter. The position peaked at $5K in Q1 2019. 318 funds tracked by Wall St. Rank hold GWPH as of Q2 2019.

  • Buffington Mohr McNeal reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2019 after selling out during the quarter.
  • Buffington Mohr McNeal sold 30 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2019, an estimated $5K.
  • Buffington Mohr McNeal first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q1 2019 and held it in 1 quarter.
  • Buffington Mohr McNeal's GW Pharmaceuticals Plc American Depositary Shares position peaked at $5K in Q1 2019.
  • 318 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2019.

Based on Buffington Mohr McNeal's 13F filing for Q2 2019, filed 31 Jul 2019.